Overview
Efficacy of Topical Cysteamine in Nephropathic Cyctinosis
Status:
Completed
Completed
Trial end date:
2016-03-01
2016-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to evaluate the efficacy of topical cysteamine eye drops in the treatment of corneal cystine crystals deposits in patients with nephropathic cystinosis.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
The Eye Center and The Eye Foundation for Research in OphthalmologyTreatments:
Cysteamine
Ophthalmic Solutions
Criteria
Inclusion Criteria:- patients with confirmed diagnosis of nephropathic cystinosis
- leucocyte cystine concentration level of more than 2.0 nmol half-cystine/ mg protein
- clinical evidence of tissue deposition of cystine and tissue damage due to cystinosis
Exclusion Criteria:
- Allergy to cysteamine